---
title: "CLSA Sticks to Its Buy Rating for Hangzhou Tigermed Consulting Co., Ltd. Class H (5HZ1)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284666469.md"
description: "CLSA has reaffirmed its Buy rating for Hangzhou Tigermed Consulting Co., Ltd. Class H (5HZ1) with a price target of HK$56.10, while the shares closed at HK$44.00. The analyst consensus for the company is Strong Buy, with a price target consensus of €6.14."
datetime: "2026-04-30T00:47:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284666469.md)
  - [en](https://longbridge.com/en/news/284666469.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284666469.md)
---

# CLSA Sticks to Its Buy Rating for Hangzhou Tigermed Consulting Co., Ltd. Class H (5HZ1)

In a report released on April 28, from CLSA maintained a Buy rating on Hangzhou Tigermed Consulting Co., Ltd. Class H, with a price target of HK$56.10. The company’s shares closed last Tuesday at HK$44.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Hangzhou Tigermed Consulting Co., Ltd. Class H has an analyst consensus of Strong Buy, with a price target consensus of €6.14.

### Related Stocks

- [03347.HK](https://longbridge.com/en/quote/03347.HK.md)
- [300347.CN](https://longbridge.com/en/quote/300347.CN.md)

## Related News & Research

- [Tigermed Says Probe Into Major Shareholders Will Not Hit Operations](https://longbridge.com/en/news/286261011.md)
- [Hangzhou Tigermed Unveils Up to RMB1 Billion A-Share Buyback Plan](https://longbridge.com/en/news/286280793.md)
- [Berenberg Bank Reaffirms Their Buy Rating on tonies SE Class A (TNIE)](https://longbridge.com/en/news/286369468.md)
- [Hangzhou Tigermed issues unaudited 2026 first-quarter report](https://longbridge.com/en/news/284352795.md)
- [Maxim Group Sticks to Its Buy Rating for Newsmax Inc. Class B (NMAX)](https://longbridge.com/en/news/286573867.md)